The immunometabolic ecosystem in cancer
GR Bantug, C Hess - Nature Immunology, 2023 - nature.com
Our increased understanding of how key metabolic pathways are activated and regulated in
malignant cells has identified metabolic vulnerabilities of cancers. Translating this insight to …
malignant cells has identified metabolic vulnerabilities of cancers. Translating this insight to …
Acid-sensing ion channel 1a modulation of apoptosis in acidosis-related diseases: implications for therapeutic intervention
Z Zhang, M Chen, W Zhan, Y Chen, T Wang… - Cell Death …, 2023 - nature.com
Acid-sensing ion channel 1a (ASIC1a), a prominent member of the acid-sensing ion channel
(ASIC) superfamily activated by extracellular protons, is ubiquitously expressed throughout …
(ASIC) superfamily activated by extracellular protons, is ubiquitously expressed throughout …
[HTML][HTML] Molecular landmarks of tumor disulfidptosis across cancer types to promote disulfidptosis-target therapy
D Zhao, Y Meng, Y Dian, Q Zhou, Y Sun, J Le, F Zeng… - Redox Biology, 2023 - Elsevier
The mystery about the mechanistic basis of disulfidptosis has recently been unraveled and
shows promise as an effective treatment modality for triggering cancer cell death. However …
shows promise as an effective treatment modality for triggering cancer cell death. However …
B cell lymphoma 6 promotes hepatocellular carcinoma progression by inhibiting tumor infiltrating CD4+T cell cytotoxicity through ESM1
J Li, J Feng, Z Li, Y Ni, L Liu, X Lei, Z Chai… - NPJ Precision …, 2024 - nature.com
Immunotherapy exhibited potential effects for advanced hepatocellular carcinoma,
unfortunately, the clinical benefits are often countered by cancer adaptive immune …
unfortunately, the clinical benefits are often countered by cancer adaptive immune …
Metabolic engineering for optimized CAR-T cell therapy
SJ McPhedran, GA Carleton, JJ Lum - Nature Metabolism, 2024 - nature.com
The broad effectiveness of T cell-based therapy for treating solid tumour cancers remains
limited. This is partly due to the growing appreciation that immune cells must inhabit and …
limited. This is partly due to the growing appreciation that immune cells must inhabit and …
Long-Term Survival of Patients with Stage T1N0M1 Renal Cell Carcinoma
V Schütz, H Lin, A Kaczorowski, S Zschäbitz, D Jäger… - Cancers, 2023 - mdpi.com
Simple Summary Localized renal cell carcinoma (RCC) has an excellent prognosis.
However, once metastatic, patient prognosis declines significantly. There is a rare patient …
However, once metastatic, patient prognosis declines significantly. There is a rare patient …
[HTML][HTML] STAC3 as a poor prognostic biomarker in renal clear cell carcinoma: relationship with immune infiltration
Y Zhang, J Li, L Feng, Y Cheng, L Shi… - American Journal of …, 2024 - ncbi.nlm.nih.gov
Abstract Calcium ions (Ca 2+) are crucial in tumorigenesis and progression, with their
elevated levels indicating a negative prognosis in Kidney Renal Clear Cell Carcinoma …
elevated levels indicating a negative prognosis in Kidney Renal Clear Cell Carcinoma …
UnitedMet harnesses RNA-metabolite covariation to impute metabolite levels in clinical samples
Comprehensively studying metabolism requires the measurement of metabolite levels.
However, in contrast to the broad availability of gene expression data, metabolites are rarely …
However, in contrast to the broad availability of gene expression data, metabolites are rarely …